#firstconnectdigital - Techseriesinsight

February 16, 2026
Business Wire
Artificial Intelligence, News

Global Survey Shows Rising Investment in AI Decision Intelligence

AI Decision Intelligence survey findings reveal that executives are prioritizing advanced analytics to improve credit risk and fraud decisions. According to new research sponsored by Provenir, 60% of global...

February 16, 2026
Business Wire
Biotechnology, News

Worldwide Clinical Trials Completes Catalyst Acquisition

Worldwide Clinical Trials acquisition marks a significant expansion in the global contract research organization (CRO) landscape. Worldwide Clinical Trials has officially completed its acquisition of Catalyst Clinical Research, a...

February 16, 2026
Business Wire
Artificial Intelligence, News

Chronus Launches Change Adoption Solution to Drive Behavior Change

The Chronus Change Adoption solution is designed to help organizations address the human side of transformation. Chronus, a mentoring and connection platform for the future of work, has introduced...

February 16, 2026
PRNewswire
Cloud, Internet of Things (IoT), News

Pedestrian Entrance Control Systems Market to Reach US$3.4 Billion by 2033

The pedestrian entrance control systems market is set for strong growth, with projections indicating it will reach US$3.4 billion by 2033. According to insights from Persistence Market Research, the...

February 16, 2026
PRNewswire
Healthcare, News

Retevmo Adjuvant Therapy Improves Event-Free Survival in RET+ NSCLC

Retevmo adjuvant therapy has demonstrated a substantial event-free survival benefit in early-stage RET fusion-positive non-small cell lung cancer (NSCLC). Eli Lilly and Company announced positive topline results from the...

February 16, 2026
Business Wire
Biotechnology, News

Nucleome Therapeutics Appoints Dr. Michelle Morrow as Chief Scientific Officer

Nucleome Therapeutics CSO appointment marks a significant leadership milestone as Nucleome Therapeutics names Dr. Michelle Morrow as its new Chief Scientific Officer, effective 23 February 2026. The appointment strengthens...

February 16, 2026
Business Wire
Biotechnology, News

SC Infliximab Retreatment Shows Sustained Efficacy After Drug Holiday

SC infliximab retreatment has demonstrated the ability to restore and maintain disease control in patients with inflammatory bowel disease after a treatment interruption. New findings from Celltrion, Inc. show...

February 16, 2026
PRNewswire
Artificial Intelligence, News

X-Humanoid Launches Embodied Tien Kung 3.0 Humanoid Robot Platform

The Beijing Innovation Center of Humanoid Robotics, also known as X-Humanoid, has officially introduced the Embodied Tien Kung 3.0. The new humanoid robotics platform focuses on openness, usability, and...

February 16, 2026
PRNewswire
Artificial Intelligence, News

Cognizant Expands Google Cloud Partnership to Accelerate Agentic AI

Cognizant has expanded its strategic partnership with Google Cloud to operationalize agentic AI at enterprise scale. The collaboration moves beyond platform integration. It now focuses on execution, governance, and...

February 13, 2026
PRNewswire
Blockchain Technology, News

Bioretec Rights Issue Under Review to Strengthen Capital Strategy

Bioretec Ltd has announced that its Board of Directors is evaluating a potential Bioretec rights issue to support the company’s financial strategy. The proposed offering could raise approximately EUR...